We expressed the high affinity nerve growth factor receptor TrkA in Chinese hamster ovary (CHO) fibroblasts to study nerve growth factor (NGF) trafficking and processing events following receptormediated ligand internalization in a nonneuronal and p75 minus cell line. These stable clonal cell lines express approximately 2.5 ϫ 10 5 TrkA receptors and bind 125
I-NGF with high affinity (K d
ϭ 4 ϫ 10
Ϫ10
M). The TrkA receptors are autophosphorylated on tyrosine residues upon NGF stimulation and are capable of tyrosine phosphorylating downstream signaling molecules. The t 1/2 of 125 I-NGF internalization is 5 min, and the probability of an occupied TrkA receptor internalizing within 1 min at 37 C is 9.8%. By 2 h following endocytosis, less than 10% of internalized 125 I-NGF is degraded, as determined by TCA precipitation. Thirty minutes following ligand endocytosis, endocytosed 125 I-NGF is delivered back to the cell surface and released by the cell (retroendocytosis), possibly by remaining associated with recycling TrkA receptors. We measured the effect of acidification on 125 I-NGF-TrkA association and found that, at pH 6, 40% of 125 I-NGF remains bound. Thus, NGF may remain associated with the TrkA receptor at low pH conditions in the endosome and can thereby be targeted back to the plasma membrane for release by the cell. In conclusion: 1) TrkA, in the absence of p75, is fully capable of mediating 125 I-NGF endocytosis; 2) internalized 125 I-NGF is slowly and inefficiently degraded; 3) following internalization, 125 I-NGF is retroendocytosed; and 4) the ability of 125 I-NGF to remain receptor-associated during acidic conditions may provide a mechanism for its retroendocytosis via recycling TrkA vesicles. (Endocrinology 139: [3232] [3233] [3234] [3235] [3236] [3237] [3238] [3239] [3240] 1998) N ERVE GROWTH FACTOR is a polypeptide hormone that exists as a dimer of 26,500 daltons (1) . Although studies with NGF have focused largely on its role in the survival and maintenance of a subset of developing and maturing neuronal cells, evidence is now emerging that nonneuronal functions in the endocrine and immune systems can also be attributed to NGF (2) (3) (4) (5) (6) . NGF binds two distinct receptors: TrkA, a 140-kDa transmembrane receptor tyrosine kinase, and p75, a member of the tumor necrosis factor (TNF) receptor and Fas (Apo1-1/CD95) superfamily. TrkA, the high affinity NGF receptor, is necessary and sufficient for several NGF mediated biological effects (7) (8) (9) (10) (11) (12) (13) (14) ; the role of p75 in NGF stimulated signal transduction is thus not clear. However, some recent evidence of p75 participation in NGF mediated signaling events, alone (15) or in collaboration with TrkA (16) , is now emerging. Receptor-mediated NGF internalization (17) can be mediated through TrkA (18 -20) , but the role of p75 in this process is still controversial (7, 21, 22) .
NGF endocytosis has been characterized in neuronal cells and in the sympathetic neuronal-like PC12 cell line (23) . It has been established that NGF internalization in neuronal cells occurs via retrograde transport of the growth factor from the nerve terminals to the cell body (24) . Clearly, fibroblasts and other nonneuronal cells differ morphologically from neuronal cells due to the absence of axons. Retrograde transport, therefore, plays no role in NGF uptake in these cells. Since endocrine and immune functions of NGF have been established, we pursued the characterization of NGF internalization in a nonneuronal cell line, i.e. transfected fibroblasts stably expressing TrkA. Many neuronal cell lines coexpress Trk and p75. Internalization mediated through p75 in the absence of Trk has been examined in glial cell lines (21) , in sympathetic neurons (24) , and in mutant PC12 (PC12nnr) cell lines (7, 22) , however, little information is published on NGF internalization and subsequent trafficking and processing events in a p75 minus cell line. Thus, our studies in CHO/ TrkA cells address NGF internalization, processing, and trafficking in a nonneuronal context and in the absence of p75.
Endocytosis, a general and distinctive property of all eukaryotic cells, refers to the uptake of macromolecular material into a membrane-limited organelle in a living cell. The process of receptor-mediated endocytosis is comprised of noncovalent binding of ligand to cell-surface receptors, which induces the clustering of these complexes in clathrincoated pits (25) (26) (27) . The ligand-receptor complexes are internalized as coated pits invaginate and pinch off to form small intracellular coated vesicles. Clathrin is rapidly removed from the vesicles giving rise to endosomes (28, 29) . In these structures, acidification takes place, followed by a sorting step which establishes the destination of receptor and ligand. Receptors and ligands can be recycled to the cell surface (30, 31) , degraded by lysosomal enzymes, or sequestered in an intracellular compartment. We designate the intact ligand recycling process retroendocytosis (32) (33) (34) (35) , sometimes referred to as recycling, exocytosis, diacytosis, transcytosis, or re-externalization in the literature.
TrkA endocytosis has not been well characterized, but recent evidence suggests that TrkA receptors are internalized by a clathrin-mediated mechanism (19) . Our findings describe these events of 125 I-NGF internalization, processing, and retroendocytosis mediated through the TrkA receptor in the absence of p75. We find that 125 I-NGF is capable of efficient internalization and retroendocytosis, and propose that its ability to stay associated with the TrkA receptor under acidic conditions diverts it from lysosomal degradation. 
Materials and Methods Materials

Cell culture
CHO/TrkA cells were maintained in HAMS/F12 medium supplemented with 10% FCS, 1 ϫ GlutaMAX-1, 50 g/ml gentamicin sulfate, 500 g/ml G418 at 5% CO 2 . PC12 cells were routinely grown in DME/ high glucose supplemented with 10% horse serum, 5% FCS, 1 ϫ GlutaMAX-1, 50 g/ml gentamicin sulfate at 7.5% CO 2 .
Generation of stable CHO/TrkA cells pDM69 was digested with EcoRI to excise the human TrkA cDNA insert. The ends of the insert were blunted and ligated into the polylinker region of the EcoRV-digested CLDN vector. CHO cells were transfected with this plasmid via the lipofectamine method followed by G418 selection (500 g/ml). Clonal cell lines were established and individual clones were screened for TrkA expression by 125 I-NGF binding.
I-NGF equilibrium binding studies
1 ϫ 10 5 CHO/TrkA cells per well were plated into six-well plates 2 days before binding study, such that on the day of the experiment, 4 ϫ 10 5 cells/well were present. After rinsing twice with ice-cold PBS, 900 l KRP-HEPES binding buffer including 1 ng/ml final (1 ϫ 10 5 cpm) 125 I-NGF were added per well, immediately followed by addition of 100 l of 10 ϫ cold NGF of varying final concentrations ranging from 1-1000 ng/ml. After overnight incubations at 4 C, unbound ligand was removed by three PBS washes, cells were lysed in 0.4 n NaOH, and cpms were determined in ␥-counter. Curve fitting and data analysis were performed with LIGAND software version 4.1 (NIH) (36) .
p75 Western blotting
Fifty micrograms of PC12 and CHO/TrkA protein were subjected to 7.5% SDS-PAGE. After transfer onto Immobilon, the membranes were incubated for 1 h at RT in TBS/0.1% Tween20 (TBST) containing 1% BSA, followed by a 2-h incubation with anti-p75 antibody (1:1000) in TBST. After several washes with TBST, a 30-min incubation with goat antirabbit IgG-HRP (1:1000) was performed at RT. Following washing with TBST, enhanced chemiluminescence (ECL) was performed.
Western blotting with anti-Trk antibody 1087
CHO and CHO/TrkA cells plated in 60 mm plates were lysed in 200 l lysis buffer (30 mm Tris, pH 7.5, 150 mm NaCl, 1% TX-100, 0.5% deoxycholate, 10 mm EDTA, 0.1% SDS, 1 mm PMSF, 800 KIU/ml aprotinin, 1 m leupeptin, 1 mm sodium orthovanadate, 160 mm sodium fluoride). After centrifugation at 14,000 rpm, protein concentrations were determined with the supernatants and 50 g of protein were subjected to 7.5% SDS-PAGE. After transfer of proteins onto Immobilon, the membrane was incubated in TBST/2% BSA for 1 h at RT followed by incubation with polyclonal anti-Trk antibody 1087 (1:2000) for 2 h in TBST/2% BSA at RT. After several washes in TBST, goat antirabbit IgG-HRP (1:2000) was added for 30 min followed by detection with ECL.
Immunoprecipitation with anti-Trk antiserum 203
CHO/TrkA cells were plated in 60 mm dishes and starved the following day for 48 h in HAMS/F12/0.1% BSA. Cells were treated for 5 min with or without 100 ng/ml NGF, immediately washed with ice-cold PBS and lysed in 750 l lysis buffer. After centrifugation at 14,000 rpm, 4 l anti-Trk antisera 203 were added to each supernatant followed by rotation for 2 h at 4 C. Immunocomplexes were precipitated with protein A sepharose beads. Beads were washed 4 times, boiled in 100 l 1 ϫ Laemmli's buffer and 40 l were subjected to 7.5% SDS-PAGE, followed by Western blotting with antiphosphotyrosine antibody PY20 (1:1000 in TBST/2.5% BSA). The same membrane was stripped for 10 min in 0.5 m NaCl/0.5 m acetic acid at RT. After blocking in TBST/2.5% BSA, the membrane was reprobed with polyclonal anti-Trk antibody 1087 (1: 2000) to verify equal protein loading.
I-NGF internalization
CHO/TrkA cells were plated at 50% confluency the day before the experiment in six-well plates. Cells were rinsed twice with ice-cold PBS and once with KRP-HEPES binding buffer (pH 7.5). Cells were incubated at 37 C in the presence of 1 ng/ml 125 I-NGF in binding buffer for various times, followed by aspiration of unbound ligand and three washes with 2 ml ice-cold binding buffer. One milliliter acidic binding buffer (pH 3.5) was added per well, and cells were transferred to 4 C for 10 min to remove surface-bound ligand. This acid wash plus one additional 1 ml wash were transferred to a borosilicate culture tube. Cells were washed 3 more times with 2 ml acidic binding buffer and lysed with 1 ml 0.4 n NaOH for 30 min. Lysates and one additional 1 ml wash were transferred to separate tube. Acid-extractable and nonextractable cpms were measured in ␥-counter.
The method for determining the endocytic rate constant of occupied receptors was previously described (25, 26, 32) . Briefly, internalized and surface radioactivity was measured as described above at 1-min intervals for 6 min. Surface values were integrated over time using the trapezoidal rule, and values were plotted against internalized cpms. The slope of the plot at any point is equal to the specific internalization rate of occupied receptors (K e ) at that time. Linear regression was performed using Statview, Abacus Concepts, Inc. (Berkeley, CA).
Internalized
I-NGF degradation
Cells were treated for various times with 1 ng/ml 125 I-NGF at 37 C. Acid-extractable 125 I-NGF was collected and counted, and acid-resistant 125 I-NGF was subjected to 7.5% TCA precipitation. Cells were lysed in 1 ml 0.4 N NaOH/1%BSA for 15 min, and 500 l of lysate were incubated with 500 l 15% TCA on ice for 30 min. Samples were centrifuged at 14,000 rpm and supernatants plus one 7.5% TCA wash were transferred to tube. Cpms of pellet and supernatants were determined in a ␥-counter. In our hands, this method is consistently 70 -80% efficient, as determined by the ability of intact 125 I-NGF to precipitate. The TCA precipitation method has been used previously to monitor 125 I-NGF degradation (21, 37) . Treatment with 0.4 N NaOH does not contribute to 125 I-NGF degradation.
Retroendocytosis
CHO/TrkA cells were plated as described above 1-2 days before the experiment. Cells were washed twice with ice-cold PBS and once with binding buffer (pH 7.5). One milliliter of 3 ng/ml 125 I-NGF in binding buffer was added per well, and cells were incubated for 20 min at 37 C. Unbound ligand was immediately aspirated and surface-bound ligand was removed by acid wash as described above. Cells were washed two more times with acidic binding buffer, twice with PBS, and once with binding buffer (pH 7.5). 1 ml of 37 C binding buffer was added per well, and cells were transferred to 37 C for various times. At the appropriate time, 500 l media were transferred to an Eppendorf tube containing 500 l 15% TCA. TCA precipitation procedure was followed as above. The cells were washed 3 times with PBS and lysed, and counted as above.
Tris-Tricine gel electrophoresis of TCA precipitated 125 I-NGF
TCA pellets from parallel 10-and 30-min media time-points in the retroendocytosis experiment above were washed with ice-cold acetone, and the pellet was solubilized in 50 l 4 ϫ Tris-Tricine sample buffer (0.1 m Tris-HCl, pH 6.8, 24% glycerol, 1% SDS, 2% ␤-mercaptoethanol, 0.02% Coomassie G-250). After boiling for 10 min and centrifugation at 14,000 rpm, the samples were subjected to 16.5% Tris-Tricine gel electorphoresis at 100 V using Bio-Rad's Tris-Tricine Ready Gels for peptides and small proteins. For molecular weight controls, 0.1 Ci of 125 I-NGF, 7.5% TCA-precipitated 125 I-NGF (0.1 Ci before TCA-precipitation), and BioRad's peptide and small protein molecular weight marker were also included. The gel was placed in 40% methanol/10% acetic acid fixative solution for 30 min. The molecular weight lane was cut off from the rest of the gel and stained for 1 h in 0.025% Coomassie Blue G-250 for 1 h and destained in 10% acetic acid for 3 ϫ 15-min washes. The rest of the gel was wrapped in plastic and placed on film for 50 days and developed.
pH binding studies CHO/TrkA cells were incubated with 1 ng/ml 125 I-NGF in KRP-HEPES binding buffer, pH 6 -8, at 4 C overnight in the presence and absence of 330 ng/ml unlabeled NGF to determine specific binding.
Results
I-NGF equilibrium binding analysis
We performed NGF competition binding studies in CHO/ TrkA cells at equilibrium conditions (4 C, overnight) and subjected the data to Scatchard analysis to obtain an equilibrium binding constant and the number of receptor binding sites per cell. The ligand displacement curve demonstrates an IC 50 of 3 ϫ 10 Ϫ9 m (Fig. 1A) and Scatchard analysis ( , personal communication) . The absence of p75 in these clones was verified by Western blotting experiments with an antihuman p75 antibody raised against the highly conserved extracellular domain of p75. p75 expression is clearly detectable in PC12 cells, but no immunoreactivity was observed even when 100 g of cell lysates were used (Fig. 2) 
TrkA mediates tyrosine phosphorylation
To further ascertain TrkA expression in our cell lines, we conducted Western blotting experiments with 50 g of protein obtained from CHO parental and TrkA cDNA transfected cells and demonstrate the presence of an approximately 140-kDa protein that is immunoreactive with polyclonal anti-Trk antibody 1087 in CHO/TrkA cells but not in CHO parental cells (Fig. 3A) . The fainter approxi- mately 110-kDa band, which is also immunoreactive with the anti-Trk antibody, is most likely the high-mannose precursor to mature TrkA (19, 39) . To assess TrkA function, we performed immunoprecipitation experiments with protein obtained from NGF-stimulated CHO/TrkA cells using anti-Trk antiserum 203 and analyzed the tyrosine phosphorylation state of the immunoprecipitated protein. Western blot analysis with antiphosphotyrosine antibody PY20 indicates that a 140-kDa tyrosine phosphorylated protein is clearly detectable in cells stimulated for 5 min with NGF but not in the basal state, demonstrating TrkA's ability to autophosphorylate in these cells (Fig. 3B, left panel) . TrkA is maximally tyrosine phosphorylated between 5 and 10 min, and even at 30 min continues to be phosphorylated above basal levels (data not shown). To verify that similar amounts of protein were immunoprecipitated with anti-trk antiserum 203 in the basal and NGF stimulated state, the membrane was stripped and reprobed with anti-trk antibody 1087. Clearly, equal amounts of TrkA are present (Fig. 3B, right panel) . The 25-and 50-kDa bands represent the rabbit IgG light and heavy chains, respectively, as polyclonal antibodies were employed for immunoprecipitation and Western blotting. In addition, Western blot analysis of protein obtained from NGF stimulated cells with the antiphosphotyrosine antibody PY20 revealed an increase in the tyrosine phosphorylation states of several cellular proteins, including a 140-kDa protein, presumably TrkA, as early as 1 min following NGF treatment (Fig. 3C) , clearly demonstrating that TrkA is capable of mediating further downstream tyrosine phosphorylation events. Together, these ligand binding and phosphorylation studies demonstrate that CHO/TrkA cells express functional TrkA receptors capable of mediating autophosphorylation and tyrosine phosphorylation of downstream signaling proteins.
I-NGF internalization
Because cell surface ligand is acid extractable, whereas intracellular 125 I-NGF is not, the ability to distinguish surface-bound from internalized 125 I-NGF allowed us to determine a t 1/2 of 5 min for NGF endocytosis. After 2 h, 72.4% of cell-associated 125 I-NGF was found intracellularly (Fig. 4A) . We performed kinetic studies, according to the method of Wiley and Cunningham (40, 41) , to obtain a value for the endocytic rate constant (K e ), the cellular constant that defines the probability of an occupied receptor (i.e. TrkA) being internalized in 1 min at 37 C. By integrating the amount of surface bound 125 I-NGF (acid-released 125 I-NGF) at early time points and plotting each value vs. the amount of internalized 125 I-NGF at the same time-point, the K e is derived from the slope of the plot (Fig. 4B) . The K e for the 125 I-NGFTrk complex is 0.098; i.e. there is a 9.8% probability that an occupied Trk receptor will internalize in 1 min at 37 C.
I-NGF degradation
Degradation of internalized 125 I-NGF was monitored by the TCA precipitation method. This approach has been previously used to measure 125 I-NGF degradation in PC12 and glial cell lines (21, 37) . Figure 5 shows the time-course of the various components of cell associated radioactivity. The cells were incubated with 125 I-NGF and at each time point acid extractable (cell surface) and nonextractable (internalized) cpms were determined. The intracellular 125 I-NGF was further subdivided into degraded and intact components. As can be seen, during the early part of the time course, most of the cell associated radioactivity was surface bound, but at approximately 30 min, surface binding of 125 I-NGF reaches steady state while internalization progressively continues. At 120 min 75% is internalized and 25% is surface-bound, and of the internalized 125 I-NGF 95% is intact and 5% degraded.
Retroendocytosis
Internalized ligand can either undergo lysosomal degradation or bypass this route and travel back to the cell surface, where endosomal fusion with the plasma membrane can result in the release of intact ligand. Delivery of ligand to the lysosome results in degradation followed by the release of fragments into the surrounding medium. By quantitating the relative amounts of degraded vs. intact ligand released into the medium after internalization, we were able to evaluate NGF's ability to undergo retroendocytosis. Cells were incubated with 3 ng/ml 125 I-NGF for 20 min at 37 C to allow for ligand internalization; surface-bound ligand was then removed by acid-wash, and the cells were reincubated in 37 C buffer to follow the release of the internalized 125 I-ligand. At various times after this reincubation, media was collected and assayed for intactness of ligand by the TCA precipitation method (Fig. 6A) . TCA-precipitable (intact) ligand is already detectable 5 min after reincubation (i.e. 25 min after the onset of internalization), whereas TCA-soluble (degraded) 125 I-NGF does not appear until 10 min after reincubation. After 90 min, approximately 60% of released ligand is TCA-precipitable, indicating that 125 I-NGF is preferentially sorted into a recycling, rather than lysosomal degradation pathway.
To determine if TCA-precipitable 125 I-NGF includes partially degraded 125 I-NGF, we subjected resolubilized TCA pellets from the 10-and 30-min retroendocytosis time-points (corresponding to 30 and 50 min after the onset of internal- ization) to gel electrophoresis using 16.5% Tris-Tricine gels that allow for the separation of peptides and small proteins. We compared the molecular weights of the TCA-precipitated 125 I-NGF obtained from these time-points to the original intact tracer 125 I-NGF and to TCA-precipitated intact tracer 125 I-NGF. As can be seen in Fig. 6B , the molecular weight of the bands in lanes 3 and 4 (30-and 10-min time-points, respectively) comigrate with the 13-kDa bands obtained (right panel). In all panels, the 140-kDa TrkA receptor is indicated by an arrow. C, CHO/TrkA lysates from unstimulated and 1 min NGF stimulated cells were subjected to SDS-PAGE followed by Western blotting analysis with antibody PY20. . NGF usually exists as a dimer of 26 kDa; however, the reducing conditions in this experiment yield NGF monomers. No bands of molecular weight less than 13,000 were visible, demonstrating that the TCA precipitation method is valid for separating intact from degraded NGF. Together, these studies demonstrate that NGF is capable of retroendocytosis and that the TCA precipitation method is valid for separating intact from degraded 125 I-NGF.
The effect of pH on
I-NGF binding
As the endosome undergoes maturation, the vesicular milieu becomes increasingly acidic resulting in dissociation of ligand-receptor complexes. Because 125 I-NGF preferentially undergoes retroendocytosis, rather than entering a degradation pathway, we hypothesized that 125 I-NGF stays bound to its receptor despite the decreases in pH, and thereby returns to the cell-surface by continuing association with a recycling receptor. To assess this idea, we analyzed the effect of changes in pH on 125 I-NGF binding to whole cells. Although 125 I-NGF binding decreases in response to a fall in pH, this effect is much less than for other peptide hormone receptor complexes (6) , and even at pH 6, 40% of maximal binding remained (Fig. 7) . This finding suggests a possible mechanism underlying the efficient NGF recycling observed in these cells.
Discussion
Since many TrkA expressing cell lines also express p75, it has proven difficult to determine the individual contributions of each receptor to NGF internalization. Others have addressed this issue by taking advantage of the different affinities of NGF for its two receptors, and by using p75 blocking antibodies or an NGF mutant to determine TrkA's role in endocytosis (20, 42) . Although p75 binding is decreased in these studies, this low affinity receptor could still interact with TrkA and, thereby, modulate NGF internalization. Researchers have also used the mutant PC12nnr cell line, which no longer responds to NGF and contains primarily low affinity (presumably p75) binding sites, to address the contribution of p75 to NGF internalization. Results in these cell lines are contradictory; i.e. Green et al. (7) detected no NGF internalization, whereas Eveleth and Bradshaw (22) detected some NGF endocytosis, albeit characteristically different from parental PC12 cells. These studies highlight the difficulties in dissecting the relative contributions of the individual receptors to NGF endocytosis in cell lines coexpressing TrkA and p75. Kahle et al. (20) have addressed this problem by characterizing NGF endocytosis mediated through p75 in a glial Trk minus cell line. Although it has been demonstrated in Trk expressing NIH3T3 cells that the Trk receptor is capable of mediating NGF endocytosis (18) , thorough analysis determining the TrkA endocytic rate constant, kinetics of NGF degradation, and NGF retroendocytosis in a cell line without p75 has not been reported. We, therefore, addressed these issues in a p75 minus cell line.
Our findings corroborate Jing et al.'s observation in NIH3T3 cells that TrkA can mediate efficient and rapid NGF internalization, in the absence of p75. Because we have previously performed the same experiments with insulin and IGF-I in fibroblasts (6), we are able to compare them to our findings in this study with NGF. The endocytic rate constants for IGF-I, NGF, and insulin are 0.07, 0.1, and 0.2 min Ϫ1 , respectively, indicating that 125 I-NGF-bound TrkA's probability of internalizing within 1 min at 37 C is approximately half that of insulin's. Although these studies do not address the mechanism underlying this observation, various possibilities that aren't mutually exclusive exist. The binding affinities of the ligands for their receptors may differ, permitting a higher affinity ligand to internalize more rapidly. However, all these ligands bind their respective tyrosine kinase receptors with affinities in the low nm range, thus rendering this possibility an unlikely mechanism for the observed differences in endocytic rate constants. Alternatively, the rates at which the various receptors diffuse in the plasma membrane and pass through a coated pit may differ, which could account for different internalization kinetics. Furthermore, the efficiency with which ligand-receptor-complexes become trapped in coated pits and the rate at which coated pits give rise to endosomes may differentially affect rates of receptor-mediated endocytosis. Potentially distinct 125 I-NGF was subjected to TCA precipitation, as described in Materials and Methods. Values depicted represent the mean cpms Ϯ SEM (for some data points too small to be seen) of one of three independent experiments with similar results, each performed in triplicate.
interactions of the ligand-bound tyrosine kinase receptors with clathrin-associated proteins, such as ␣-adaptin or ␤-arrestin, may further contribute to the observed differences in internalization rates between NGF, IGF-I, and insulin. Clearly, there are many steps which participate in the modulation of internalization kinetics. This highlights the complexity and potential of regulation of growth factor action before internalization.
The majority of internalized 125 I-NGF escapes degradation, as evidenced by its absence in TCA-soluble fractions of internalized radioactivity. We propose that the ability of NGF to remain associated with its receptor in acidic conditions, indicative of the endosomal milieu, protects it from being targeted to the lysosome. The ability of NGF to remain receptor-associated is further supported by the appearance of TCA-precipitable NGF in the extracellular medium 25 min following internalization. Receptor recycling has been documented in several systems and recent cross-linking studies suggest that TrkA may recycle between 10 -30 min after initiation of internalization (19) . It is, therefore, likely, that intact NGF can return to the cell surface as the receptors are reincorporated into the plasma membrane. This is the first demonstration of NGF retroendocytosis in the absence of p75. Eveleth et al. (22) suggest that the observed retroendocytosis in PC12nnr5 cells could be due to p75 because Trk function in these mutant cells is defective. Although p75 may contribute to NGF retroendocytosis, we demonstrate that TrkA is sufficient for this process.
Other potential mechanisms may also contribute to NGF's efficient retroendoctyosis. To our knowledge, no endosomal NGF degradation enzyme has been discovered, unlike is the case for insulin, which is degraded by an endosomal acidic thiol metalloprotease that functions optimally at low pH (43) . Thus, the absence of endosomal degradation may serve to protect NGF's integrity. An alternative mechanism by which NGF may be protected from degradation may be through its interaction with low affinity binding sites that, according to binding analysis, may be present on these cells. The identity of these binding sites is unknown; perhaps they are binding proteins that protect NGF from degradation.
Tyrosine kinase receptors and their respective ligands activate a multitude of identical signal transduction molecules, yet their biological effects are distinct. It has been suggested that specificity of growth factor action can be achieved by differences in the kinetics of activation of signaling proteins. Others have published that NGF elicits a higher and more sustained level of ERK1/2 activation in comparison to other growth factors (44 -47) , and we have observed similar findings in CHO/TrkA cells (unpublished observations). It is possible that a ligand is able to mediate signaling events not only at the plasma membrane but continues to do so from the endosome, provided it is still bound to its receptor. The hypothesis that internalized ligand-receptor complexes can extend the signaling process initiated at the plasma membrane was proposed by Posner et al. (48, 49) and several studies (50, 51) have addressed this in the insulin and EGF receptor system. Furthermore, Grimes et al. (19) demonstrate that endosomal TrkA receptors remain associated with NGF, are autophosphorylated, and associate with PLC-␥, suggesting that endocytosed ligand-receptor complexes can continue to participate in signal transduction events. Thus, strong and sustained ERK1/2 activation in the case of NGF could be the direct result of prolonged internalized ligandreceptor association and lack of NGF lysosomal degradation. Perhaps NGF cannot fulfill its biological functions adequately unless it is internalized. This can be tested by measuring NGF's biological effects in cell lines expressing Trk receptor mutants, which lack the ability to internalize yet maintain their tyrosine kinase activity upon ligand-binding. Because we observed very efficient retroendocytosis of NGF, it is possible that retroendocytosed NGF could bind once again to cell-surface receptors and thereby continue to activate downstream molecules, such as ERK1/2. Thus, we hypothesize that the processes following receptor-mediated endocytosis, including ligand-receptor dissociation, ligand degradation, and ligand trafficking, can play critical roles in imparting growth factor specificity.
It has been previously suggested that functions of receptor-mediated ligand internalization include down-regulation of receptors and termination of signal transduction. However, recent evidence suggesting the ability of endosomal ligand-receptor pairs to contribute to signal transduction, modifies this original view. The function of receptormediated endocytosis may be to regulate, either positively or negatively, ligand initiated signaling events. NGF, a chronically required factor involved in cell survival and differentiation, may sustain signaling through relatively longer association with its receptor, its ability to bypass lysosomal degradation, and subsequent retroendocytosis.
